73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
How Can You Increase Your Red Blood Cells?

How Can You Increase Your Red Blood Cells?

How Can You Increase Your Red Blood Cells?Maintaining optimal levels is important for your healthByHeidi Moawad, MDUpdated on April 17, 2023Medically reviewed byJeffrey S. Land

How Can You Increase Your Red Blood Cells?

How Can You Increase Your Red Blood Cells?Maintaining optimal levels is important for your healthByHeidi Moawad, MDUpdated on April 17, 2023Medically reviewed byJeffrey S. Land
Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

October 6, 2023Ashling WahnerThe Medicines and Healthcare Products Regulatory Agency has authorized the use of dostarlimab in combination with chemotherapy for the treatment of patients with mismatch

Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

October 6, 2023Ashling WahnerThe Medicines and Healthcare Products Regulatory Agency has authorized the use of dostarlimab in combination with chemotherapy for the treatment of patients with mismatch
European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients

European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients
Cancer survivor feared recurrence, but this time it was his heart

Cancer survivor feared recurrence, but this time it was his heart

Heart attack survivor Doug Cobb. Photo: Caitriona CobbDoug Cobb popped a couple antacid pills to calm the heartburn he'd been experiencing on and off for weeks. The 60-year-old considered he might

Cancer survivor feared recurrence, but this time it was his heart

Heart attack survivor Doug Cobb. Photo: Caitriona CobbDoug Cobb popped a couple antacid pills to calm the heartburn he'd been experiencing on and off for weeks. The 60-year-old considered he might
Blood Thinners: What You Should Know

Blood Thinners: What You Should Know

Blood Thinners: What You Should KnowByAngela Ryan Lee, MDPublished on January 24, 2022Medically reviewed byAnisha Shah, MDBlood thinners are medications used to treat and

Blood Thinners: What You Should Know

Blood Thinners: What You Should KnowByAngela Ryan Lee, MDPublished on January 24, 2022Medically reviewed byAnisha Shah, MDBlood thinners are medications used to treat and
What Causes Blood Clots in Stool?

What Causes Blood Clots in Stool?

What Causes Blood Clots in Stool?ByPamela Assid, DNP, RNUpdated on November 01, 2023Medically reviewed byKimberly Brown, MDBlood clots in stool can have a number of possible ca

What Causes Blood Clots in Stool?

What Causes Blood Clots in Stool?ByPamela Assid, DNP, RNUpdated on November 01, 2023Medically reviewed byKimberly Brown, MDBlood clots in stool can have a number of possible ca
How Successful Is Immunotherapy for Breast Cancer?

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the
EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

September 18, 2023Kristi RosaThe European Medicines Agency has granted Priority Medicines designation to iopofosine I-131 for use in patients with Waldenström macroglobulinemia in patients who previou

EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

September 18, 2023Kristi RosaThe European Medicines Agency has granted Priority Medicines designation to iopofosine I-131 for use in patients with Waldenström macroglobulinemia in patients who previou
Who Gets Laryngeal (Voice Box) Cancer?

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al